Effect of combination of microneedling with tranexamic acid on modified MASI score in patients of melasma
DOI:
https://doi.org/10.66344/jpad.v31i1.1701Abstract
Objective To determine the percentage reduction in modified MASI score with combination of microneedling and tranexamic acid in patients of melasma.
Methods This descriptive case series involved 66 patients of both genders aged 18-40 years having moderate to severe melasma. These patients were treated by microneedling with tranexamic acid at 0, 4 and 8 weeks. Baseline modified MASI scores at 0 weeks was calculated and outcome was evaluated after 12 weeks in the form of percentage reduction in the initial modified MASI scores, both clinically and photographically. Response was graded as excellent (>75% reduction), very good (50-74%), good (25-49%) and fair (<25%).
Results A total of 66 patients with moderate to severe melasma were enrolled. Majority of the patients (53%) showed very good response, 41% had good response, 4.5% had excellent response while only 1.5% patients showed fair response. No serious side effects were noted.
Conclusion Microneedling in conjunction with tranexamic acid showed very good response (50-74% improvement) in majority of the patients.
References
1. Budamakuntla L, Loganathan E, et al. A randomised, open label, comparative study of tranexamic acid microinjections and traxenxamic acid with microneedling in patients with melasma. J Cutan Aesthet Surgery. 2013;6(3):139–43.
2. Grimes PE. Melasma: Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453–7.
3. Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Dermatol. 2013;23(2):143-8
4. Bentley-Phillips B, Bayles MA. Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation. S Afr Med J. 1975;49:1391–5.
5. Hurley ME, Guervara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol. 2002;138:1578–82.
6. Li YH, Chen JZ, Wei HC, Wu Y, Liu M, Xu YY, et al. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg. 2008;34:693–700.
7. Singh A, Yadav S. Microneedling: Advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244–54.
8. Kalluri H, Banga AK. Microneedles and transdermal drug delivery. J Drug Delivery Sci Technol. 2009;19:303–10.
9. Lima EA. Microneedling in facial recalcitrant melasma: report of a series of 22 cases. An Bras Dermatol. 2015;90:919–21.
10. Maeda K, Naganuma M. Topical trans-4- aminomethyl cyclohexanecarboxylic acid Photobiol. 1998;47:130–41
11. Poojary S, Minni K. Tranexamic acid in melasma: a review. Pigment Disord. 2015;2:288.
12. Yuan C, Wang XM, Yang LJ, Wu PL. Tranexamic acid accelerates skin barrier recovery and upregulates occludin in damaged skin. Int J Dermatol. 2014; 53:959–65.
13. Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27:35–39.
14. Lee HC, Thng TG, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75:385–92.
15. Aamir S, naseem R. Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study. J Pak Assoc Dermatol. 2014;24(3):198-203.
16. Saleh FY, Abdel-Azim ES, Ragaie MH, Guendy MG. Topical tranexamic acid with microneedling versus microneedling alone in treatment of melasma: clinical, histopathologic, and immunohistochemical study. J Egypt Womens Dermatol Soc. 2019;16:89-96.
17. Ejaz A, Raza N, Iftikhar N, Muzzafar F. Comparison of 30% salicylic acid with Jessner's solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak. 2008;18(4):205-8.
18. Desale SP, Gugle AS, Kote R, Jadhav VM. Comparative study of efficacy of glycolic acid peel and intense pulsed light in the treatment of melasma. J Med Sci 2015;2(1):39-48.
19. Sharma R, Mahajan VK, Mehta KS, Chauhan PS, Rawat R, Shiny TN. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study. Clin Exp Dermatol. 2017;42(7):728-34.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Bushra Hassan, Lamees Mahmood Malik, Tariq Rashid, Sommiya Anum, Wasfa Hayat, Sumera Hanif
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
